News beats

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

Psychedelics Today Ep. 448: Deborah C. Mash, Ph.D. – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

Opium Addiction Market expected to rise – BioCorRx Inc, Delpor Inc, DemeRx Inc, Alar Pharmaceuticals, expected to drive market

Advocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study

Kentucky’s $42 million allocation for psychedelics research for opioid addiction

Rewiring an Addicted Brain | Deborah Mash – The Lindsey Elmore Show (podcast)

Are Psychedelics The Solution To The Opioid Crisis? – Dr. Mark Hyman

10 Psychedelics CEOs To Pay Attention To In 2022

Breaking the Cycle of Opioid Dependence with ibogaine

Goop podcast: The Future of Addiction Treatment